Results 141 to 150 of about 26,127 (297)

Publication Only

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Safety and Phosphate‐Binding Capacity of Oxylanthanum Carbonate in Healthy Volunteers

Clinical and Translational Science
Despite the widespread use of currently available serum phosphate management options, elevated serum phosphate is common in patients with end‐stage kidney disease on dialysis.
Pablo E. Pergola, Melanie S. Joy, Armando Garsd, Steve J. Hasal, Atul Khare, Guru Reddy, Pramod Gupta, William F. Finn   +7 more
doaj   +1 more source

Guidelines for writing definitions in ontologies [PDF]

, 2017
Ontologies are being used increasingly to promote the reusability of scientific information by allowing heterogeneous data to be integrated under a common, normalized representation. Definitions play a central role in the use of ontologies both by humans
Ruttenberg, Alan, Seppälä, Selja, Smith, Barry   +2 more
core   +1 more source

Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemia [PDF]

, 2004
Adamasco Cupisti, Claudia D’Alessandro, Rita Báldi, Giuliano Barsotti   +3 more
openalex   +1 more source

Relationship of Conjunctival and Corneal Calcification with Secondary Hyperparathyroidism in Hemodialysis Patients [PDF]

, 2003
Background/Objective: Hyperphosphatemia is the consequence of end stage renal failure. Inadequate control of serum phosphorus results in elevated Ca×P product with subsequent soft tissue deposition in the form of conjunctival and corneal calcification ...
Baradaran, A., Doroudgar, F., Ganji, F., Nasri, H.   +3 more
core  

Spurious hyperphosphatemia in a patient with alteplase-locked central venous catheter [PDF]

, 2005
François Cachat, Daniel Bardy, Claudine Durussel, Ermindo R. Di Paolo   +3 more
openalex   +1 more source

Dietary Management of Hyperphosphatemia [PDF]

American Journal of Kidney Diseases, 2018
Vishnu S. Potluri, Shivam Joshi, Siddharth P. Shah   +2 more
openaire   +3 more sources

Effectiveness and safety of a 6-month treatment with paricalcitol in patients on hemodialysis with secondary hyperparathyroidism

Brazilian Journal of Nephrology
Introduction: The mineral bone disorder, particularly secondary hyperparathyroidism, in chronic kidney disease (CKD) has a systemic impact affecting not only bone metabolism.
Inés Olaizola, Hena Caorsi, Laura Fajardo, Alejandro Ferreiro, Nieves Campistrus, Deyanira Dolinsky, Alicia Petraglia, Pablo Ambrosoni   +7 more
doaj   +1 more source

Correlation among Hyperphosphatemia, Type II Sodium–Phosphate Transporter Activity, and Vitamin D Metabolism in Fgf‐23 Null Mice [PDF]

, 2007
Despina Sitara
openalex   +1 more source

FURTHER OBSERVATIONS ON THE RELATION OF CALCIUM AND PHOSPHORUS INTAKE TO THE HYPERCALCEMIA AND HYPERPHOSPHATEMIA INDUCED BY IRRADIATED ERGOSTEROL

, 1931
James H. Jones, Milton Rapoport
openalex   +1 more source